Abstract
Various polyphenols found in plants are able to activate biochemical pathways in mammalian cells so as to confer health benefits. These molecules include resveratrol, catechins, quercetin and genistein. There is considerable overlap between these pathways and those activated by caloric restriction. The chemicals have therefore been termed “calorie restriction mimetics”. In both cases the response induced steels the cell to resist adverse or stressful conditions. In the present chapter the effects of some of the most well studied compounds will be described. As a result of their effects cells become more resistant to oxidative stress, inflammatory pathways are suppressed, and changes are seen in the cell cycle. Resveratrol has been shown to extend lifespan in various organisms and to extinguish disease processes in obese mice, so that instead of dying early, the mice have a normal lifespan. The changes induced seem in large part to be mediated by their activation of sirtuin enzymes. Sirtuins deacetylate and thereby activate transcription factors that alter the expression of various genes involved in stress-resistance. The enormous potential that natural and synthetic sirtuin activating compounds have in prevention and treatment of type 2 diabetes, cardiovascular disease, dementia and cancer without side effects makes them of considerable topical interest clinically. Synthetic compounds whose sirtuin-activating ability is a thousand times stronger than resveratrol have been discovered and represent potential new drugs to combat common diseases of aging.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S. and Takada, Y., 2004. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24(5A), 2783–2840.
Alvira, D., Yeste-Velasco, M., Folch, J., Verdaguer, E., Canudas, A. M., Pallàs, M. and Camins, A., 2007. Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience 147, 746–756.
Ambra, R., Rimbach, G., de Pascual Teresa, S., Fuchs, D., Wenzel, U., Daniel, H. and Virgili, F., 2006. Genistein affects the expression of genes involved in blood pressure regulation and angiogenesis in primary human endothelial cells. Nutr Metab Cardiovasc Dis 16, 35–43.
Andriambeloson, E., Magnier, C., Haan-Archipoff, G., Lobstein, A., Anton, R., Beretz, A., Stoclet, J. C. and Andriantsitohaina, R., 1998. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr 128, 2324–2333.
Anekonda, T. S., 2006. Resveratrol – a boon for treating Alzheimer’s disease? Brain Res Rev 52, 316–326.
Anton, S., Melville, L. and Rena, G., 2006. Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. Cell Signal 19, 378–383.
Antonello, M., Montemurro, D., Bolognesi, M., Di Pascoli, M., Piva, A., Grego, F., Sticchi, D., Giuliani, L., Garbisa, S. and Rossi, G. P., 2007. Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 20, 1321–1328.
Araki, T., Sasaki, Y. and Milbrandt, J., 2004. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010–1013.
Barger, J. L., Kayo, T., Pugh, T. D., Prolla, T. A. and Weindruch, R., 2008. Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Exp Gerontol 43, 859–866.
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., Pistell, P. J., Poosala, S., Becker, K. G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K. W., Spencer, R. G., Lakatta, E. G., Le Couteur, D. G., Shaw, R. J., Navas, P., Puigserver, P., Ingram, D. K., de Cabo, R. and Sinclair, D. A., 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337–342.
Baur, J. A. and Sinclair, D. A., 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493–506.
Bloedon, L. T., Jeffcoat, A. R., Lopaczynski, W., Schell, M. J., Black, T. M., Dix, K. J., Thomas, B. F., Albright, C., Busby, M. G., Crowell, J. A. and Zeisel, S. H., 2002. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 76, 1126–1137.
Bohm, M., Rosenkranz, S. and Laufs, U., 2004. Alcohol and red wine: impact on cardiovascular risk. Nephrol Dial Transplant 19, 11–16.
Bove, K., Lincoln, D. W. and Tsan, M. F., 2002. Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem Biophys Res Commun 291, 1001–1005.
Burgering, B. M. T. and Kops, G. J. P. L., 2002. Cell cycle and death control: long live Forkheads. Trends Biochem Sci 27, 352–360.
Buryanovskyy, L., Fu, Y., Boyd, M., Ma, Y., Hsieh, T. C., Wu, J. M. and Zhang, Z., 2004. Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43, 11417–11426.
Busby, M. G., Jeffcoat, A. R., Bloedon, L. T., Koch, M. A., Black, T., Dix, K. J., Heizer, W. D., Thomas, B. F., Hill, J. M., Crowell, J. A. and Zeisel, S. H., 2002. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 75, 126–136.
Byun, H. S., Song, J. K., Kim, Y. R., Piao, L., Won, M., Park, K. A., Choi, B. L., Lee, H., Hong, J. H., Park, J., Seok, J. H., Lee, Y. J., Kang, S. W. and Hur, G. M., 2008. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 47, 301–308.
Cai, J. B., Zhang, Z. H., Xu, D. J., Qian, Z. Y., Wang, Z. R., Huang, Y. Z., Zou, J. G. and Cao, K. J., 2008. Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells. Clin Exp Pharmacol Physiol 35, 1419–1425.
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P. and Auwerx, J. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056–1060.
Cassidy, A., 2003. Potential risks and benefits of phytoestrogen-rich diets. Int J Vitam Nutr Res 73, 120–126.
Chan, A. Y., Dolinsky, V. W., Soltys, C. L., Viollet, B., Baksh, S., Light, P. E. and Dyck, J. R., 2008a. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem 283, 24194–24201.
Chan, S. L., Tabellion, A., Bagrel, D., Perrin-Sarrado, C., Capdeville-Atkinson, C. and Atkinson, J., 2008b. Impact of chronic treatment with red wine polyphenols (RWP) on cerebral arterioles in the spontaneous hypertensive rat. J Cardiovasc Pharmacol 51, 304–310.
Chen, Y. M., Ho, S. C., Lam, S. S., Ho, S. S. and Woo, J. L., 2003. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88, 4740–4747.
Chen, J., Shoe, Y., Mueller-Steiner, S., Chen, L. F., Kwon, H., Yi, S., Mucke, L. and Gan, L., 2005. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kB signaling. J Biol Chem 280, 40364–40374.
Chen, Y., Tseng, S. H., Lai, H. S. and Chen, W. J., 2004. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 136, 57–66.
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R. and Sinclair, D. A., 2004. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390–392.
Conti, B., Sanchez-Alavez, M., Winsky-Sommerer, R., Morale, M. C., Lucero, J., Brownell, S., Fabre, V., Huitron-Resendiz, S., Henriksen, S., Zorrilla, E. P., de Lecea, L. and Bartfai, T., 2006. Transgenic mice with a reduced core body temperature have an increased life span. Science 314, 825–828.
Corson, T. W. and Crews, C. M., 2007. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell Metab 130, 769–774.
Crowell, J. A., Korytko, P. J., Morrissey, R. L., Booth, T. D. and Levine, B. S., 2004. Resveratrol-associated renal toxicity. Toxicol Sci 82, 614–619.
Cullen, K. M., Kócsi, Z. and Stone, J., 2006. Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages. Neurobiol Aging 27, 1786–1796.
Das, S., Alagappan, V. K., Bagchi, D., Sharma, H. S., Maulik, N. and Das, D. K., 2005. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul Pharmacol 42, 281–289.
Dashwood, R. H., Myzak, M. C. and Ho, E., 2006. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 27, 344–349.
Ehrnhoefer, D. E., Duennwald, M., Markovic, P., Wacker, J. L., Engemann, S., Roark, M., Legleiter, J., Marsh, J. L., Thompson, L. M., Lindquist, S., Muchowski, P. J. and Wanker, E. E., 2006. Green tea (–)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington’s disease models. Hum Mol Genet 15, 2743–2751.
Elmali, N., Baysal, O., Harma, A., Esenkaya, I. and Mizrak, B., 2007. Effects of resveratrol in inflammatory arthritis. Inflammation 30, 1–6.
Fang, M. Z., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. and Yang, C. S., 2003. Tea polyphenol (–)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63, 7563–7570.
Feige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J. and Auwerx, J., 2008. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 8, 347–358.
Ferry-Dumazet, H., Garnier, O., Mamani-Matsuda, M., Vercauteren, J., Belloc, F., Billiard, C., Dupouy, M., Thiolat, D., Kolb, J. P., Marit, G., Reiffers, J. and Mossalayi, M. D., 2002. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23, 1327–1333.
Flesch, M., Schwarz, A. and Bohm, M., 1998. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol 275, H1183–H1189.
Frankel, E. N., Waterhouse, A. L. and Kinsella, J. E., 1993. Inhibition of human LDL oxidation by resveratrol. Lancet 341, 1103–1104.
Fremont, L., Belguendouz, L. and Delpal, S., 1999. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci 64, 2511–2521.
Fröjdö, S., Cozzone, D., Vidal, H. and Pirola, L., 2007. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J 406, 511–518.
Fujiki, H., 2005. Green tea: health benefits as cancer preventive for humans. Chem Rec 5, 119–132.
Fulda, S. and Debatin, K. M., 2004. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 64, 337–346.
Garvin, S., Ollinger, K. and Dabrosin, C., 2006. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 231, 113–122.
Glaser, V., 1999. Billion-dollar market blossoms as botanicals take root. Nat Biotechnol 17, 17–18.
Green, N. S., Foss, T. R. and Kelly, J. W., 2005. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Proc Natl Acad Sci USA 102, 14545–14550.
Grinberg, L. N., Newmark, H., Kitrossky, N., Rahamim, E., Chevion, M. and Rachmilewitz, E. A., 1997. Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharmacol 54, 973–978.
Gross, D. N., van den Heuvel, A. P. and Birnbaum, M. J., 2008. The role of FoxO in the regulation of metabolism. Oncogene 27, 2320–2336.
Guarente, L. and Picard, F., 2005. Calorie restriction – the SIR2 connection. Cell 120, 473–482.
Guo, Q., Zhao, B., Li, M., Shen, S. and Xin, W., 1996. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim Biophys Acta 1304, 210–212.
Guo, Q., Zhao, B., Shen, S., Hou, J., Hu, J. and Xin, W., 1999. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim Biophys Acta 1427, 13–23.
Handschin, C. and Spiegelman, B. M., 2008. The role of exercise and PGC1a in inflammation and chronic disease. Nature 454, 463–469.
Harikumar, K. B. and Aggarwal, B. B., 2008. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7, 1020–1035.
Harper, C. E., Patel, B. B., Wang, J., Arabshahi, A., Eltoum, I. A. and Lamartiniere, C. A., 2007. Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 28, 1946–1953.
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., Pahor, M., Javors, M. A., Fernandez, E. and Miller, R. A. 2009. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395.
Hider, R. C., Liu, Z. D. and Khodr, H. H., 2001. Metal chelation of polyphenols. Methods Enzymol 335, 190–203.
Higdon, J. V. and Frei, B., 2003. Tea catechins and <polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43, 89–143.
Hodgson, J. M., 2006. Effects of tea and tea flavonoids on endothelial function and blood pressure: a brief review. Clin Exp Pharmacol Physiol 33, 838–841.
Howes, M. J. and Houghton, P. J., 2003. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 75, 513–527.
Howes, M. J., Perry, N. S. and Houghton, P. J., 2003. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders. Phytother Res 17, 1–18.
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L., Scherer, B. and Sinclair, D. A., 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191–196.
Howitz, K. T. and Sinclair, D. A., 2008. Xenohormesis: sensing the chemical cues of other species. Cell 133, 387–391.
Huang, Z., Wang, C., Wei, L., Wang, J., Fan, Y., Wang, L., Wang, Y. and Chen, T., 2008. Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells. Biochem Biophys Res Commun 374, 517–521.
Iso, H., Date, C., Wakai, K., Fukui, M. and Tamakoshi, A., 2006. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 144, 554–562.
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C. and Pezzuto, J. M., 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218–220.
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T. H., DePinho, R. A., Sharpless, N. E. and Scadden, D., 2006. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443, 421–426.
Jones, S. B., DePrimo, S. E., Whitfield, M. L. and Brooks, J. D., 2005. Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 14, 596–604.
Juge, N., Mithen, R. F. and Traka, M., 2007. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64, 1105–1127.
Jung-Hynes, B., Nihal, M., Zhong, W. and Ahmad, N., 2009. Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition? J Biol Chem 284, 3823–3832.
Kahyo, T., Ichikawa, S., Hatanaka, T., Yamada, M. K. and Setou, M., 2008. A novel chalcone polyphenol inhibits the deacetylase activity of SIRT1 and cell growth in HEK293T cells. J Pharmacol Sci 108, 364–371.
Kao, Y. H., Hiipakka, R. A. and Liao, S., 2000. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141, 980–987.
Khanna, D., Sethi, G., Ahn, K. S., Pandey, M. K., Kunnumakkara, A. B., Sung, B., Aggarwal, A. and Aggarwal, B. B., 2007. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 7, 344–351.
Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., Puigserver, P., Sinclair, D. A. and Tsai, L. H., 2007. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. EMBO J 26, 3169–3179.
Kimura, Y. and Okuda, H., 2001. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131, 1844–1849.
Koo, S.-H. and Montminy, M., 2006. In vino veritas: a tale of two Sirt1 s? Cell 127, 1091–1093.
Koubova, J. and Guarente, L., 2003. How does calorie restriction work? Genes Dev 17, 313–321.
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S. and Sharpless, N. E., 2006. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443, 453–457.
Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., Nakaya, N., Nishino, Y., Tsubono, Y. and Tsuji, I., 2006. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296, 1255–1265.
Kuzuhara, T., Sei, Y., Yamaguchi, K., Suganuma, M. and Fujiki, H., 2006. DNA and RNA as new binding targets of green tea catechins. J Biol Chem 281, 17446–17456.
Kwon, H. S. and Ott, M., 2008. The ups and downs of SIRT1. Trends Biochem Sci 33, 517–525.
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P. and Auwerx, J., 2006. Resveratrol Improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 127, 1109–1122.
Lambert, J. D. and Yang, C. S., 2003. Mechanisms of cancer prevention by tea constituents. J Nutr 133, 3262–3267.
Lamming, D. W., Wood, J. G. and Sinclair, D. A., 2004. Small molecules that regulate lifespan: evidence for xenohormesis (Review). Mol Microbiol 53, 1003–1009.
Lefèvre, J., Michaud, S. E., Haddad, P., Dussault, S., Ménard, C., Groleau, J., Turgeon, J. and Rivard, A., 2007. Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide. FASEB J 21, 3845–3852.
Leighton, F., Miranda-Rottmann, S. and Urquiaga, I., 2006. A central role of eNOS in the protective effect of wine against metabolic syndrome. Cell Biochem Funct 24, 291–298.
Leikert, J. F., Rathel, T. R., Wohlfart, P., Cheynier, V., Vollmar, A. M. and Dirsch, V. M., 2002. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106, 1614–1617.
Li, C., Allen, A., Kwagh, J., Doliba, N. M., Qin, W., Najafi, H., Collins, H. W., Matschinsky, F. M., Stanley, C. A. and Smith, T. J., 2006. Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem 281, 10214–10221.
Li, H. F., Chen, S. A. and Wu, S. N., 2000. Evidence for the stimulatory effect of resveratrol on Ca2+-activated K+ current in vascular endothelial cells. Cardiovasc Res 45, 1035–1045.
Liu, Z., Song, Y., Zhang, X., Liu, Z., Zhang, W., Mao, W., Wang, W., Cui, W., Zhang, X., Jia, X., Li, N., Han, C. and Liu, C., 2005. Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin Exp Pharmacol Physiol 32, 1049–1054.
Magrone, T., Candore, G., Caruso, C., Jirillom, E. and Covellim, V., 2008. Polyphenols from red wine modulate immune responsiveness: biological and clinical significance. Curr Pharm Des 14, 2733–2748.
Mandel, S. A., Avramovich-Tirosh, Y., Reznichenko, L., Zheng, H., Weinreb, O., Amit, T. and Youdim, M. B., 2005. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 14, 46–60.
Mattson, M. P. and Cheng, A., 2006. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci 29, 632–639.
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Pern, R. B., Vu, C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y., Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D., Olefsky, J. M., Jirousek, M. R., Elliott, P. J. and Westphal, C. H., 2007. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712–716.
Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E. and Morrison, S. J., 2006. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448–452.
Morris, B. J., 2005. A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer. J Hypertens 23, 1285–1309.
Morris, B. J., 2007. Climate not cultivars in the NO-ing of red wines. J Hypertens 25, 501–503.
Morris, B. J., 2008. How xenohormetic compounds confer health benefits. In Le Bourg, E., Rattan, S. I. S. (eds), Mild Stress: Applying Hormesis in Aging Research and Interventions. Springer, Amsterdam, Netherlands, pp. 115–138.
Mukherjee, D., Nissen, S. E. and Topol, E. J., 2001. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286, 954–959.
Myzak, M. C. and Dashwood, R. H., 2006. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets 7, 443–452.
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., Kang, H., Shaw, R. J. and Evans, R. M., 2008. AMPK and PPAR agonists are exercise mimetics. Cell 134, 405–415.
Nigdikar, S. V., Williams, N. R., Griffin, B. A. and Howard, A. N., 1998. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 68, 258–265.
Oberdoerffer, P., Michan, S., McVay, M., Mostoslavsky, R., Vann, J., Park, S. K., Hartlerode, A., Stegmuller, J., Hafner, A., Loerch, P., Wright, S. M., Mills, K. D., Bonni, A., Yankner, B. A., Scully, R., Prolla, T. A., Alt, F. W. and Sinclair, D. A., 2008. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135, 907–918.
Okamoto, K., 2006. Habitual green tea consumption and risk of an aneurysmal rupture subarachnoid hemorrhage: a case-control study in Nagoya, Japan. Eur J Epidemiol 21, 367–371.
Ono, K., Condron, M. M., Ho, L., Wang, J., Zhao, W., Pasinetti, G. M. and Teplow, D. B., 2008. Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J Biol Chem 283, 32176–32178.
Orallo, F., Alvarez, E., Camina, M., Leiro, J. M., Gomez, E. and Fernandez, P., 2002. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 61, 294–302.
Park, O. J. and Surh, Y. J., 2004. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett 150, 43–56.
Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H. and Néri, C., 2005. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 37, 349–350.
Pearson, K. J., Baur, J. A., Lewis, K. N., Peshkin, L., Price, N. L., Labinskyy, N., Swindell, W. R., Kamara, D., Minor, R. K., Perez, E., Jamieson, H. A., Zhang, Y., Dunn, S. R., Sharma, K., Pleshko, N., Woollett, L. A., Csiszar, A., Ikeno, Y., Le Couteur, D., Elliott, P. J., Becker, K. G., Navas, P., Ingram, D. K., Wolf, N. S., Ungvari, Z., Sinclair, D. A. and de Cabo, R., 2008. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8, 157–168.
Peng, G., Dixon, D. A., Muga, S. J., Smith, T. J. and Wargovich, M. J., 2006. Green tea polyphenol (–)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog 45, 309–319.
Perez-Vizcaino, F., Duarte, J. and Andriantsitohaina, R., 2006. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. (Review). Free Radic Res 40, 1054–1065.
Pirola, L. and Fröjdö, S., 2008. Resveratrol: one molecule, many targets. IUBMB Life 60, 323–332.
Raskin, I., Ribnicky, D. M., Komarnytsky, S., Ilic, N., Poulev, A., Borisjuk, N., Brinker, A., Moreno, D. A., Ripoll, C., Yakoby, N., O’Neal, J. M., Cornwell, T., Pastor, I. and Fridlender, B., 2002. Plants and human health in the twenty-first century. Trends Biotechnol 20, 522–531.
Ravindranath, M. H., Muthugounder, S., Presser, N. and Viswanathan, S., 2004. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 546, 121–165.
Ray, P. S., Maulik, G., Cordis, G. A., Bertelli, A. A., Bertelli, A. and Das, D. K., 1999. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 27, 160–169.
Reagan-Shaw, S., Nihal, M., and Ahmad, N. 2007. Dose translation from animal to human studies revisited. FASEB J 22, 659–661.
Renaud, S. and de Lorgeril, M., 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523–1526.
Ribaldo, P. D., Souza, D. S., Biswas, S. K., Block, K., Lopes de Faria, J. M. and Lopes de Faria, J. B., 2008. Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats. J Nutr 139, 96–100.
Rivas, M., Garay, R. P., Escanero, J. F., Cia, P., Jr., Cia, P. and Alda, J. O., 2002. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 132, 1900–1902.
Rivera, L., Morón, R., Zarzuelo, A. and Galisteo, M., 2009. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77, 1053–1063.
Robb, E. L., Winkelmolen, L., Visanji, N., Brotchie, J. and Stuart, J. A., 2008. Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. Biochem Biophys Res Commun 372, 254–259.
Räthel, T. R., Samtleben, R., Vollmar, A. M. and Dirsch, V. M., 2007. Activation of endothelial nitric oxide synthase by red wine polyphenols: impact of grape cultivars, growing area and the vinification process. J Hypertens 25, 541–549.
Santos, E. L., de Picoli Souza, K., da Silva, E. D., Batista, E. C., Martins, P. J., D’Almeida, V. and Pesquero, J.B. 2009. Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats. Biochem Pharmacol 78, 951–958.
Sarkar, F. H. and Li, Y., 2002. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev 21, 265–280.
Sasazuki, S., Kodama, H., Yoshimasu, K., Liu, Y., Washio, M., Tanaka, K., Tokunaga, S., Kono, S., Arai, H., Doi, Y., Kawano, T., Nakagaki, O., Takada, K., Koyanagi, S., Hiyamuta, K., Nii, T., Shirai, K., Ideishi, M., Arakawa, K., Mohri, M. and Takeshita, A., 2000. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 10, 401–408.
Sevov, M., Elfineh, L. and Cavelier, L. B., 2006. Resveratrol regulates the expression of LXR-α in human macrophages. Biochem Biophys Res Commun 348, 1047–1054.
Shakibaei, M., Csaki, C., Nebrich, S. and Mobasheri, A., 2008. Resveratrol suppresses interleukin-1b-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 76, 1426–1439.
Sharma, S., Anjaneyulu, M., Kulkarni, S. K. and Chopra, K., 2006. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 76, 69–75.
Shen, M. Y., Hsiao, G., Liu, C. L., Fong, T. H., Lin, K. H., Chou, D. S. and Sheu, J. R., 2007. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Br J Haematol 139, 475–485.
Sinclair, D. A. and Guarente, L., 1997. Extrachromosomal rDNA circles – a cause of aging in yeast. Cell 91, 1033–1042.
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., Simon, D. K., Bachoo, R. and Spiegelman, B. M., 2006. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397–408.
Stefani, M., Markus, M. A., Lin, R. C. Y., Pinese, M., Dawes, I. A. and Morris, B. J., 2007. The effect on resveratrol on a cell model of human aging. Ann NY Acad Sci 1114, 407–418.
Su, H. C., Hung, L. M. and Chen, J. K., 2006. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 290, E1339–E1346.
Su, J. L., Yang, C. Y., Zhao, M., Kuo, M. L. and Yen, M. L., 2007. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem 282, 19385–19398.
Suchankova, G., Nelson, L. E., Gerhart-Hines, Z., Kelly, M., Gauthier, M. S., Saham, A. K., Ido, Y., Puigserver, P. and Ruderman, N. B., 2009. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 378, 836–841.
Szewczuk, L. M., Forti, L., Stivala, L. A. and Penning, T. M., 2004. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem 279, 22727–22737.
Tessitore, L., Davit, A., Sarotto, I. and Caderni, G., 2000. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression. Carcinogenesis 16, 1619–1622.
Thandapilly, S. J., Wojciechowski, P., Behbahani, J., Louis, X. L., Yu, L., Juric, D., Kopilas, M. A., Anderson, H. D. and Netticadan, T. 2010. Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure. Am J Hypertens (Epub ahead of print Nov 26, 2009).
Trosko, J. E., 2008. Role of diet and nutrition on the alteration of the quality and quantity of stem cells in human aging and the diseases of aging. Curr Pharm Des 14, 2707–2718.
Tseng, S. H., Lin, S. M., Chen, J. C., Su, Y. H., Huang, H. Y., Chen, C. K., Lin, P. Y. and Chen, Y., 2004. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10, 2190–2202.
Tsuneki, H., Ishizuka, M., Terasawa, M., Wu, J. B., Sasaoka, T. and Kimura, I., 2004. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol 4, 18.
Ungvari, Z., Orosz, Z., Rivera, A., Labinskyy, N., Xiangmin, Z., Olson, S., Podlutsky, A. and Csiszar, A., 2007. Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol 292, H2417–H2424.
Urpi-Sarda, M., Jauregui, O., Lamuela-Raventos, R. M., Jaeger, W., Miksits, M., Covas., M. I. and Andres-Lacueva, C., 2005. Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal Chem 77, 3149–3155.
Vijg, J. and Campisi, J., 2008. Puzzles, promises and a cure for ageing. Nature 454, 1065–1071.
Vitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., Rosenbaum, J. and Merillon, J. M., 2003. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72, 2219–2233.
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr. and Walle, U. K., 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 1377–1382.
Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K. and Forstermann, U., 2002. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106, 1652–1658.
Wallerath, T., Li, H., Godtel-Ambrust, U., Schwarz, P. M. and Forstermann, U., 2005. A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 12, 97–104.
Wang, Y., Branicky, R., Stepanyan, Z., Carroll, M., Guimond, M. P., Hihi, A., Hayes, S., McBride, K. and Hekimi, S., 2009. The anti-neurodegeneration drug clioquinol inhibits the aging-associated protein CLK-1. J Biol Chem 284, 314–323.
Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., Chen, L., Humala, N., Teplow, D. B. and Pasinetti, G. M., 2008a. Grape-derived polyphenolics prevent Ab oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer’s disease. J Neurosci 28, 6388–6389.
Wang, Z. Y., Huang, M. T., Lou, Y. R., Xie, J. G., Reuhl, K. R., Newmark, H. L., Ho, C. T., Yang, C. S. and Conney, A. H., 1994. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res 54, 3428–3435.
Wang, R. H., Zheng, Y., Kim, H. S., Xu, X., Cao, L., Luhasen, T., Lee, M. H., Xiao, C., Vassilopoulos, A., Chen, W., Gardner, K., Man, Y. G., Hung, M. C., Finkel, T. and Deng, C. X., 2008b. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol Cell 32, 11–20.
Westphal, C. H., Dipp, M. A. and Guarente, L., 2007. A therapeutic role for sirtuins in diseases of aging? Trends Biochem Sci 32, 555–560.
Whitsett, T., Carpenter, M. and Lamartiniere, C. A., 2006. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog 5, 15.
Wolfram, S., 2007. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26, 373S–388S.
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M. and Sinclair, D., 2004. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686–689.
Yamamoto, H., Schoonjans, K. and Auwerx, J., 2007. Sirtuin functions in health and disease: review. Mol Endocrinol 21, 1745–1755.
Yang, Y. C., Lu, F. H., Wu, J. S., Wu, C. H. and Chang, C. J., 2004. The protective effect of habitual tea consumption on hypertension. Arch Intern Med 164, 1534–1540.
Yu, C., Shin, Y. G., Chow, A., Li, Y., Kosmeder, J. W., Lee, Y. S., Hirschelman, W. H., Pezzuto, J. M., Mehta, R. G. and van Breemen, R. B., 2002. Human, rat, and mouse metabolism of resveratrol. Pharm Res 19, 1907–1914.
Zang, M., Xu, S., Maitland-Toolan, K. A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T. J. and Cohen, R. A., 2006. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55, 2180–2191.
Zhang, J., 2006. Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem J 397, 519–527.
Zhang, L., Jie, G., Zhang, J. and Zhao, B., 2009. Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress. Free Radic Biol Med 46, 414–421.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Morris, B.J. (2010). Calorie Restriction Mimetics and Aging. In: Everitt, A., Rattan, S., le Couteur, D., de Cabo, R. (eds) Calorie Restriction, Aging and Longevity. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8556-6_9
Download citation
DOI: https://doi.org/10.1007/978-90-481-8556-6_9
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-8555-9
Online ISBN: 978-90-481-8556-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)